November 21, 2021 Enzychem to Partner with Zydus Cadila to Manufacture COVID-19 Plasmid DNA Vaccine in Korea Explore further
November 8, 2021 Enzychem Files for FDA Breakthrough Therapy Designation for EC-18 for the Treatment of Chemoradiation-Induced Oral Mucositis Explore further
October 20, 2021 Enzychem Lifesciences Announces Positive Results for Phase 2 U.S. Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
September 13, 2021 Enzychem Lifesciences Announces Database Lock for Phase 2 Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
May 20, 2021 Enzychem Lifesciences Announces Poster Presentation at the 2021 Keystone Symposia Conference Explore further
